ZEALAND PHARMA A/S (ZEAL.CO)

Every figure this model derived for ZEAL.CO, the value it took, and the element in the company's own XBRL it was read from — so any of it can be checked against the filing rather than taken on trust. As at 2025-12-31.

The figures, and where each came from

This is the part no other screener shows. Each figure below names the XBRL element it was read from, so it can be checked against the filing itself.

FigureValueXBRL tagAs at
capex 33,365,000 PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities 2025-12-31
cash 3,849,000,000 CashAndCashEquivalents 2026-04-01
current assets 15,018,000,000 CurrentAssets 2026-04-01
current liabilities 404,000,000 CurrentLiabilities 2026-04-01
equity 14,469,000,000 Equity 2026-04-01
interest expense 332,795,000 FinanceCosts 2025-12-31
ocf 6,531,933,000 CashFlowsFromUsedInOperatingActivities 2025-12-31
revenue 9,214,860,000 Revenue 2025-12-31

The ratios

The figures themselves rather than their scores — what somebody looking up ZEAL.CO on one particular measure came for.

RatioValue
cash operating margin75.52
current ratio37.17
current ratio reported37.17
ev ebit2.73
ev owner earnings2.93
ev sales2.06
fcf margin70.52
interest cover20.91
operating margin75.52
owner earnings margin70.52
revenue growth14598.86
revenue growth per share14598.86
roic50.32
rule of 4014674.38
sbc pct revenue0.0

What to be careful about

What this model itself distrusts about ZEAL.CO's figures. Written by the derivation as it ran, not added afterwards.